Dr. Simó SchwartzWelcome to CIBBIM-Nanomedicine!! A comprehensive multidisciplinary Clinical Nanomedicine and Advanced Therapies Research Center. Created by the Catalan Health Department in 1995, we are part of the Vall d’Hebron University Hospital, the largest hospital complex in Catalonia and one of the largest in Spain , and of its research Institute –Institut de Recerca Vall d’Hebron (VHIR).

Our aim is to provide new treatments and diagnostics addressed to unmet clinical needs for the benefit of patients and society. For this, we have a full developed Research Program based on Advanced Therapies (ATMP) and Nanotechnology for Biomedical applications in human diseases.

Our main interests are the identification of new therapeutic targets, and the development oftargeted and non-targeted drug delivery systems, new diagnostic biosensors and imaging tools, advanced cell therapies and tissue based regenerative medicine. In addition, we have fully dedicated facilities to ensure adequate proof-of-concept validation and preclinical studies, in which animal models are used for addressing the efficacy and preclinical toxicity of new nanomedicines and ATMP.

To achieve higher standards and better technological approaches in this field, is of the most importance to ensure research collaborations among research groups with different biomedical, clinical and technological areas of expertise, and also to provide at the same time a good interactive environment and transnational cooperative working with adequate industrial, technological and clinical partnerships. These should ensure an optimal improvement of the actual diagnostic tools and treatment protocols of patients and will provide better survival, lower health costs and further, a considerable improvement on their overall quality of life.

Dr. Simó Schwartz Jr

Director CIBBIM-Nanomedicine